Chemoinformaics analysis of N-formylchonemorphine
Molecular Weight | 374.613 | nRot | 4 |
Heavy Atom Molecular Weight | 332.277 | nRig | 21 |
Exact Molecular Weight | 374.33 | nRing | 4 |
Solubility: LogS | -2.973 | nHRing | 0 |
Solubility: LogP | 5.113 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 24 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 71.0873 |
nHD | 1 | BPOL | 45.2827 |
QED | 0.723 |
Synth | 4.549 |
Natural Product Likeliness | 2.139 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.993 |
Pgp-sub | 0.851 |
HIA | 0.053 |
CACO-2 | -4.774 |
MDCK | 0.0000114 |
BBB | 0.528 |
PPB | 0.459442 |
VDSS | 1.478 |
FU | 0.439828 |
CYP1A2-inh | 0.264 |
CYP1A2-sub | 0.342 |
CYP2c19-inh | 0.107 |
CYP2c19-sub | 0.95 |
CYP2c9-inh | 0.105 |
CYP2c9-sub | 0.06 |
CYP2d6-inh | 0.646 |
CYP2d6-sub | 0.915 |
CYP3a4-inh | 0.903 |
CYP3a4-sub | 0.591 |
CL | 12.522 |
T12 | 0.094 |
hERG | 0.767 |
Ames | 0.21 |
ROA | 0.676 |
SkinSen | 0.963 |
Carcinogencity | 0.508 |
EI | 0.045 |
Respiratory | 0.938 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.642447 |